Sean MacLeod is the Founder and CEO of FenoLogica Biosciences, an early-stage synthetic biology tools company. FenoLogica’s technology accelerates the discovery and development of custom-engineered microbial platforms for biopharma and industrial bioscience applications. As an experienced executive and entrepreneur, Sean has led the commercialization efforts of numerous life science and biomedical technologies. He recently helped found Enzymetrics Biosciences, a microbiome discovery and diagnostic company with technology licensed from Pacific Northwest National Laboratory. Prior to FenoLogica, Sean was the President of Stratos Product Development, a life science and medical device consulting firm. He led the company for over a decade and grew it to be recognized worldwide as one of the top product development firms for regulated devices and leading-edge biomedical applications. He is an active mentor and board advisor in the life sciences community including Life Science Washington’s WIN program (Phase Genomics, Inmedix) and the Jones + Foster Accelerator at the University of Washington (A-Alpha, Silene now part of Curi Bio). He is an executive board member of the Technology Alliance. Sean holds an MBA from the University of Washington and a BS in Mechanical Engineering from the University of Massachusetts, Amherst.

Share: